hBD-1 vs hGHRH(1-37)OH
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and hGHRH(1-37)OH (Human growth hormone-releasing factor (1-37) hydroxyl) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | hGHRH(1-37)OH |
|---|---|---|
| Category | Dental & Oral | Growth Hormone |
| Full Name | Human beta-defensin 1 | Human growth hormone-releasing factor (1-37) hydroxyl |
| Molecular Weight | 4490 Da | N/A |
| Half-Life | minutes to hours | 5-20 minutes |
| Amino Acids | 36 | 37 |
| Typical Dose | 1-10 µg/mL in experimental studies | 1-2 mcg/kg |
| Route | Topical/Intraoral | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 60 |
| Research Status | Pre-clinical | Clinical Research |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
hGHRH(1-37)OH Benefits
- ✓GH release studies
- ✓minimal-sequence mapping
- ✓receptor pharmacology
- ✓peptide stability research
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
hGHRH(1-37)OH Dosing
1-2 mcg/kg SC or IV bolus|acute stimulation with serial GH assays|short-course research administration with biomarker monitoring
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
hGHRH(1-37)OH Side Effects
- ⚠flushing
- ⚠headache
- ⚠transient fatigue
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
hGHRH(1-37)OH
Human GHRF(1-37)OH has appeared in studies examining how loss of C-terminal residues affects biological activity at the GHRH receptor. It is often used alongside other fragments to define structure-activity relationships within the GHRH family.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.